Effects of PB6 and/or chromium propionate supplementation on clinical health, growth performance, and carcass traits of high-risk cattle during the feedlot receiving and finishing periods.

The study objective was to determine the effects of PB6 and/or chromium propionate supplementation on health, growth performance, and carcass characteristics of high-risk beef cattle during a 56-d feedlot receiving period and the subsequent finishing period. Four truckload blocks of crossbred beef bulls ( = 300) and steers [ = 84; body weight (BW) = 220 ± 16.2 kg] were sourced from regional auction markets and assigned randomly to treatments arranged in a 2 × 2 factorial. The generalized complete block design consisted of 12 pen replications per treatment with pen as the experimental unit. Treatments were: 1) placebo control (CON); 2) 13 g per animal daily of PB6 (CST); 3) 450 ppb dry matter (DM) chromium propionate (CHR); and 4) 13 g per animal daily of PB6 and 450 ppb DM chromium propionate (CST + CHR). Treatments were top dressed in feed bunks daily using 0.45 kg per animal ground corn carrier immediately following feed delivery. Data were analyzed using mixed models. During the receiving period, dry matter intake (DMI) increased ( ≤ 0.03) for CST during each interim period. Overall receiving period daily DMI was 0.35 kg per animal greater for CST ( = 0.01). Cattle fed CST had greater ( ≤ 0.06) BW on days 14, 28, and 56. Likewise, average daily gain (ADG) was improved for CST from day 0 to 14 ( = 0.04) and for the overall receiving period (days 0-56; = 0.04). From days 0 to 14, CST tended ( 0.08) to increase gain:feed. During the finishing period, CHR reduced ( = 0.02) final BW and ADG (day 56 to final; = 0.01) and ADG was less for CHR over the entire feeding period (day 0 to final; = 0.03). The main effect of both CST ( = 0.02) and CHR ( = 0.03) decreased the overall treatment rate for bovine respiratory disease (BRD), and CST reduced overall antimicrobial treatment cost by $3.50 per animal compared to CON ( 0.03). Hot carcass weight (HCW) decreased ( = 0.01) in cattle fed CHR. The percentage of edible livers tended to increase (CST × CHR; = 0.08) in the CST treatment. Feed intake and growth performance outcomes during the receiving period were improved by CST but not CHR supplementation. However, both CST and CHR supplementation decreased the BRD morbidity rate. During the finishing period, performance and HCW were reduced in cattle supplemented with CHR.